For example, notable among these adverse events were anaemia (incidence ratio, 36.73%), thrombocytopenia (incidence ratio, 36.63%; 95% CrI), neutropenia (incidence ratio, 35.33%), AST increase (incidence ratio, 15.91%), and alanine aminotransferase (ALT) increase (incidence ratio, 12.01%) (eTable S3 in the Supplement). The gene discussed is GPT; the disease is anemia (phenotype).